Ivalue Infosolutions IPO Review – Dates, Price, GMP, Analysis – Should You Subscribe or Avoid?

Ivalue Infosolutions Limited is coming up with its Initial Public Offering (IPO), and investors are keen to know whether this issue is worth subscribing to. The company operates in the fast-growing enterprise digital transformation and technology services space. In this detailed IPO Review, we will cover Ivalue Infosolutions IPO Date, IPO Price, IPO Size, financial performance, valuation analysis, Grey Market Premium (GMP), reasons to invest, key risk factors, and finally, whether you should invest or avoid this IPO.

About Ivalue Infosolutions Limited

Ivalue Infosolutions Limited was incorporated in 2008 and has grown into a leading technology solutions and services provider, specializing in enterprise digital transformation. The company offers a wide range of solutions across cybersecurity, information lifecycle management, data center infrastructure, application lifecycle management, and cloud solutions.

It partners with several leading Original Equipment Manufacturers (OEMs) and System Integrators (SIs) to deliver enterprise-grade solutions. Headquartered in Bengaluru, the company has offices in eight locations in India and operations in Singapore, UAE, Sri Lanka, Bangladesh, Cambodia, and Kenya. As of March 2025, the company had 421 employees and served more than 2,800 customers globally.

Ivalue Infosolutions IPO Review Dates, Price, GMP, Analysis – Should You Subscribe or Avoid

Competitive Strengths

  • Strong Positioning in a Growing Market – Positioned uniquely in the Indian technology services and solutions market with demand driven by digital transformation.
  • Diversified Portfolio – Offers comprehensive multi-OEM solutions making it a preferred technology advisor.
  • Robust OEM Relationships – Expanding partnerships with leading global OEMs.
  • Large System Integrator Network – Over 800 system integrators with a high retention rate and repeat business.
  • Experienced Leadership – Backed by a strong leadership team with 15+ years of proven expertise.
  • Channel Strategy & Partner Ecosystem – Strategic collaborations and robust repeat business model

Ivalue Infosolutions IPO Issue Details

  • IPO Date: September 18, 2025 – September 22, 2025
  • IPO Type: Book Building Issue
  • IPO Size: ₹560.29 Crores
  • Offer for Sale (OFS): 1.87 Crore shares (entire issue is OFS)
  • Price Band: ₹284 – ₹299 per share
  • Lot Size: 50 shares
  • Minimum Retail Investment: ₹14,950 (at upper band)
  • Listing At: BSE, NSE
  • Lead Manager: IIFL Capital Services Ltd
  • Registrar: Kfin Technologies Ltd

Financial Performance

The company has shown consistent revenue and profit growth:

  • FY2023: Revenue ₹7,968 Cr | PAT ₹59.9 Cr
  • FY2024: Revenue ₹7,802 Cr | PAT ₹70.5 Cr
  • FY2025: Revenue ₹9,226 Cr | PAT ₹85.3 Cr

Key Financial Ratios (FY2025):

  • Return on Equity (ROE): 20.5%
  • Return on Capital Employed (ROCE): 27.9%
  • PAT Margin: 9.0%
  • EPS: ₹15.93
  • P/BV: 4.96

Objects of the Issue

Since this is a pure Offer for Sale (OFS), the company will not receive any proceeds. The selling shareholders (including promoters and investors) will offload part of their stake.

Valuation – P/E Ratio Comparison

  • Ivalue Infosolutions IPO P/E: 18.8x (based on FY2025 EPS of ₹15.93 and upper band price).
  • Peer – Multi Chem Ltd: P/E 10.15x
  • Industry Average: ~10.15x.

Thus, the IPO is priced at a premium compared to its global peer.

Reasons to Invest in Ivalue Infosolutions IPO

  1. Strong Industry Outlook – Rising demand for digital transformation, cloud, and cybersecurity solutions.
  2. Consistent Financial Growth – 19% revenue and 21% PAT growth YoY in FY2025.
  3. High Return Ratios – ROE above 20% and ROCE close to 28% show efficient capital utilization.
  4. Robust Partnerships – Long-term tie-ups with leading global OEMs and system integrators.
  5. Global Presence – Expanding footprint across Asia and Africa.

Risk Factors

  1. High Valuation – At 18.8x P/E, the issue looks expensive compared to peers.
  2. Entirely an OFS – No fresh issue, hence company will not benefit from the IPO proceeds.
  3. Dependence on OEMs – Heavy reliance on global OEM partners could impact margins.
  4. Competitive Market – Operates in a highly competitive IT distribution and services market.
  5. Working Capital Intensity – Large receivables and high trade payables may affect cash flows.

Grey Market Premium (GMP)

As per market observers, the Ivalue Infosolutions IPO GMP is around ₹35-40 per share as of today. This indicates moderate investor interest, translating into a 10-12% listing gain potential (subject to change).

How to Apply for Ivalue Infosolutions IPO?

  • Investors can apply through ASBA (net banking) or via UPI through their brokers or discount broker apps like Zerodha, Groww, Upstox, Angel One, ICICI Direct, etc.
  • Minimum application is 1 lot (50 shares).

Conclusion – Should You Subscribe or Avoid?

Ivalue Infosolutions IPO comes from a company with strong fundamentals, global presence, robust OEM relationships, and consistent financial growth. However, the IPO is entirely OFS and comes at a premium valuation compared to global peers. Short-term investors may see listing gains given the GMP trend, while long-term investors should weigh valuation risks.

Our View: Investors with a high-risk appetite may consider subscribing for listing gains. Conservative investors may avoid or wait for better entry post-listing.


FAQs on Ivalue Infosolutions IPO

1. What are the Ivalue Infosolutions IPO dates?
IPO opens on September 18, 2025, and closes on September 22, 2025.

2. What is the IPO Price Band?
₹284 – ₹299 per share.

3. What is the IPO Size?
₹560.29 Crores via Offer for Sale.

4. Is there any fresh issue of shares?
No. The IPO is 100% OFS.

5. What is the GMP of Ivalue Infosolutions IPO today?
Around ₹35-40 per share.

6. What is the minimum investment required?
₹14,950 (50 shares at upper price band).

7. Should I invest in Ivalue Infosolutions IPO?
Good for high-risk investors aiming for listing gains, but long-term investors should be cautious due to premium valuations.

Disclaimer: This article is for informational purposes only and is not a recommendation to buy, sell or subscribe to any IPO. The information is compiled from the company’s RHP, DRHP, and other reliable sources available in the public domain. Investors should carefully read the Red Herring Prospectus and consult their financial advisor before making any investment decision. Investing in IPOs and equities involves risk, and past performance may not be indicative of future results.

Suresh KP

Leave a Reply

Your email address will not be published. Required fields are marked *